Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 72–72 | Cite as

Axitinib/pazopanib

Hand-foot skin reaction, pancreatitis and impaired wound healing: 4 case reports
Case report
  • 9 Downloads

Reference

  1. Shah AY, et al. Outcomes of patients (PTS) with metastatic clear-cell renal cell carcinoma (mCCRCC) treated with second-line (2L) vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKI) after first-line (1L) immune checkpoint inhibitors (ICI). Journal of Clinical Oncology 36 (Suppl. 1): abstr. 682, No. 6, Feb 2018. Available from: URL: http://doi.org/10.1200/JCO.2018.36.6_suppl.682 [abstract] - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations